ZNF619 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.601750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.424800E-01
Normal-vs-Stage2
1.423550E-02
Normal-vs-Stage3
1.307560E-01
Normal-vs-Stage4
9.364400E-01
Stage1-vs-Stage2
2.015800E-01
Stage1-vs-Stage3
2.459800E-02
Stage1-vs-Stage4
4.020600E-01
Stage2-vs-Stage3
4.284100E-02
Stage2-vs-Stage4
2.451800E-01
Stage3-vs-Stage4
8.708200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.556310E-02
Normal-vs-AfricanAmerican
1.755980E-01
Normal-vs-Asian
1.012150E-01
Caucasian-vs-AfricanAmerican
7.021200E-01
Caucasian-vs-Asian
7.249800E-01
AfricanAmerican-vs-Asian
6.567200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.182170E-02
Normal-vs-Female
3.206200E-02
Male-vs-Female
5.650400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.011000E-01
Normal-vs-Age(41-60Yrs)
6.438200E-02
Normal-vs-Age(61-80Yrs)
1.024100E-02
Normal-vs-Age(81-100Yrs)
2.006300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.162200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.125400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.345620E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.458990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.017210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.734200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.665970E-02
Normal-vs-Daily Drinker
3.497600E-03
Normal-vs-Weekly Drinker
6.566000E-02
Normal-vs-Occasional Drinker
8.018100E-02
Normal-vs-Social Drinker
6.905700E-02
Non Drinker-vs-Daily Drinker
4.232400E-01
Non Drinker-vs-Weekly Drinker
8.128600E-01
Non Drinker-vs-Occasional Drinker
2.460600E-01
Non Drinker-vs-Social Drinker
1.350430E-01
Daily Drinker-vs-Weekly Drinker
3.751800E-01
Daily Drinker-vs-Occasional Drinker
5.755500E-02
Daily Drinker-vs-Social Drinker
1.879790E-02
Weekly Drinker-vs-Occasional Drinker
4.791800E-01
Weekly Drinker-vs-Social Drinker
3.136000E-01
Occasional Drinker-vs-Social Drinker
7.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.437170E-01
Normal-vs-Grade 2
7.263600E-02
Normal-vs-Grade 3
3.038200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.576000E-01
Grade 1-vs-Grade 3
3.262000E-02
Grade 1-vs-Grade 4
1.437170E-01
Grade 2-vs-Grade 3
1.520390E-01
Grade 2-vs-Grade 4
7.263600E-02
Grade 3-vs-Grade 4
3.038200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.856200E-02
Normal-vs-NonDiabetic
2.495700E-03
Diabetic-vs-NonDiabetic
4.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.224600E-01
Normal-vs-NoPancreatitis
7.203900E-03
Pancreatitis-vs-NoPancreatitis
4.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.052100E-02
Normal-vs-N1
1.757600E-02
N0-vs-N1
7.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.938600E-01
Normal-vs-TP53-NonMutant
1.408990E-01
TP53-Mutant-vs-TP53-NonMutant
6.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
